Skip to main content

Table 1 Characteristics of the patients according to the multi-drug resistant organisms (MDRO) carrier status

From: First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs

Characteristic

Total

Type of MDRO carriage

 

patients

On admission

ICU-acquired

Not carrier

P value*

 

n (%)

n (%)

n (%)

n (%)

 

Total

686 (100.0)

247 (100.0)

104 (100.0)

335 (100.0)

 

Male (yes)

405 (59.0)

149 (60.3)

63 (60.6)

193 (57.6)

0.59

Severe/critical status on admission

525 (75.5)

192 (77.7)

87 (83.7)

246 (73.4)

0.04

Previous hospitalization

190 (27.7)

121 (49.0)

46 (44.2)

125 (37.3)

0.21

Origin of patients before ICUa

- community

28 (4.1)

12 (4.9)

5 (4.8)

11 (3.3)

reference

- emergency room

115 (16.8)

40 (16.2)

30 (28.9)

45 (13.4)

1.0

- other wards

494 (72.0)

173 (70.0)

61 (58.7)

260 (77.6)

0.21

- other hospitals

30 (4.4)

13 (5.2)

6 (5.8)

11 (3.3)

0.58

- others/ no data

16 (2.3)

7 (2.8)

2 (1.9)

7 (2.1)

1.0

Invasive devices before ICU

313 (45.6)

132 (53.4)

48 (46.2)

133 (39.7)

0.24

Invasive devices in ICU

640 (93.3)

233 (94.3)

102 (98.1)

305 (91.0)

0.02

- mechanical ventilation

381 (55.5)

135 (54.7)

66 (63.5)

180 (53.7)

0.08

- indwelling urinary catheter

629 (91.7)

224 (90.7)

98 (94.2)

307 (91.6)

0.39

- intravascular catheter

514 (74.9)

200 (81.0)

88 (84.6)

226 (67.5)

0.001

Antibiotic in the last 3 months

279 (40.7)

118 (47.8)

58 (55.8)

103 (30.7)

<0.001

Antibiotic on ICU admission

586 (85.6)

204 (82.6)

89 (85.6)

293 (87.7)

0.57

- > 1 drug

232 (33.8)

82 (33.2)

39 (37.5)

111 (33.1)

0.41

Antibiotic in ICU

- none

37 (5.4)

17 (6.9)

5 (4.8)

15 (4.5)

reference

- 1 drug

314 (45.8)

107 (43.3)

33 (31.7)

174 (51.9)

0.34

- 2 drugs

210 (30.6)

69 (27.9)

28 (26.9)

113 (33.7)

0.56

- > 2 drugs (3–7)

125 (18.2)

54 (21.9)

38 (36.6)

33 (9.9)

0.04

- penicillins

8 (1.2)

3 (1.2)

0

5 (1.5)

0.60

- penicillins + inhibitors

192 (28.0)

72 (29.2)

46 (44.2)

74 (22.1)

<0.001

- cephalosporins 1st & 2nd G

155 (22.6)

51 (20.7)

13 (12.5)

91 (27.2)

0.002

- cephalosporins 3rd G /aztreonam

223 (32.5)

79 (32.0)

40 (38.5)

104 (31.0)

0.16

- carbapenems

140 (20.4)

61 (24.7)

30 (29.9)

49 (14.6)

0.001

- aminoglycosides

13 (1.9)

4 (1.6)

4 (3.9)

5 (1.5)

0.23

- fluoroquinolones

111 (16.2)

45 (18.2)

15 (14.4)

51 (15.2)

0.84

- glycopeptides

116 (16.9)

45 (18.2)

33 (31.7)

38 (11.3)

<0.001

- others

194 (28.3)

69 (27.9)

32 (30.8)

93 (27.8)

0.55

Type of discharge at 28 ICU daysb

- discharged from hospital

83 (12.1)

35 (14.2)

16 (15.4)

32 (9.6)

reference

- remain in ICU

36 (5.2)

16 (6.5)

16 (15.4)

4 (1.2)

0.001

- other ward

516 (75.2)

173 (70.0)

58 (55.8)

285 (85.3)

0.01

- death

45 (6.6)

22 (8.9)

10 (9.6)

13 (3.9)

0.44

 

Median (range)

Median (range)

Median (range)

Median (range)

 

Age (year)

66 (9–101)

65 (9–101)

66 (21–95)

67 (15–94)

0.99

Length of stay (days)

- in hospital before ICU admission

6 (0 – >60)

7 (0 – >60)

4 (0 – >60)

7 (0 – >60)

0.05

- in ICU

4 (4 – >28)

4 (1 – >28)

10 (2 – >28)

4 (1 – >28)

<0.001

- before MDR acquisition

7 (3 – >28)

0

7 (3 – >28)

-

 

Total antibiotic-days in ICU

 

3 (0 –27)

5 (0–21)

3 (0–25)

<0.001

  1. *Comparing ICU-acquired MDRO patients to non carriers; aData are missing for 3 patients; bData are missing for 6 patients